Variable | All patients | LNM | P value | ||
---|---|---|---|---|---|
Absent No.(%) | Present No.(%) | ||||
Age (years)* | 63.4 ± 11.2 [35—91] | 62.2 ± 10.4 [35—89] | 64.1 ± 10.5 [38—91] | 0.875 | |
T stage | T1 | 171 | 137 (80.1) | 34 (19.9%) | 0.734 |
T2 | 197 | 155 (78.7) | 42 (21.3) | ||
Tumor size (mm) | 33.2 ± 7.2 [12.5—43.5] | 32.2 ± 7.4 [13.5—38.5] | 34.1 ± 7.5 [12.5—43.5] | 0.123 | |
High grade nuclear | Absent | 281 | 241 (85.8) | 40 (14.2) | 0.014 |
Present | 63 | 46 (73.0) | 17 (27.0) | ||
MELF | Absent | 310 | 269 (86.8) | 41 (13.2) | < 0.001 |
Present | 34 | 18 (52.9) | 16 (47.1) | ||
Stroma reaction | Inflammatory | 56 | 49 (87.5) | 7 (12.5) | 0.100 |
Fibrosis | 230 | 195 (84.8) | 35 (15.2) | ||
Myxoid | 58 | 43 (74.1) | 15 (25.9) | ||
Histology grade pattern | 22.5 ± 19.4 [0.0—75.0] | 19.3 ± 13.7 [0.0—70.0] | 38.9 ± 17.4 [3.0—75.0] | < 0.001 | |
Lymph-vascular invasion | Absent | 220 | 200 (90.9) | 20 (9.1) | < 0.001 |
Present | 124 | 87 (70.2) | 37 (29.8) | ||
Necrosis | Absent | 293 | 260 (88.7) | 33 (11.3) | < 0.001 |
Present | 51 | 27 (52.9) | 24 (47.1) | ||
Mitosis | 7.3 ± 3.1 [1.0—16.0] | 6.8 ± 2.9 [1.0—14.0] | 9.8 ± 2.9 [3.0—16.0] | < 0.001 | |
FIGO | G1 | 51 | 48 (94.1) | 3 (5.9) | < 0.001 |
G2 | 185 | 165 (89.2) | 20 (10.8) | ||
G3 | 108 | 74 (68.5) | 34 (31.5) | ||
Silverberg | G1 | 86 | 82 (95.3) | 4 (4.7) | < 0.001 |
G2 | 175 | 149 (85.1) | 26 (14.9) | ||
G3 | 83 | 56 (67.5) | 27 (32.5) |